Tango Therapeutics, Inc. 4

Robert Azelby received 5,740 RSUs and a stock option for 35,910 shares of Tango Therapeutics, Inc. common stock at a $27.97 exercise price as part of an equity compensation grant.

On June 19, 2026, reporting person Robert Azelby of Tango Therapeutics, Inc. received an equity compensation package consisting of 5,740 shares of common stock in the form of restricted stock units (RSUs) and a stock option grant for 35,910 shares with an exercise price of $27.97 per share. The RSUs will vest in three substantially equal annual installments following the grant date, contingent on continued service, and represent a new award (no cash purchase occurred). The stock options are also newly granted and will vest and become exercisable in 36 substantially equal monthly installments over three years, again subject to continued service, with an expiration date in 2036. Following these awards, Azelby holds 35,910 shares of common stock underlying the RSUs plus the separate 35,910-share stock option, reflecting routine equity-based compensation rather than open-market buying or selling.

Filing Facts

CIK

1819133

Ticker

TNGX

Form

4

Source Type

sec

Accession

0001193125-26-279871

Alert Tier

5